Ligand · A0I
A0I · [(2~{R},3~{S},4~{R},5~{R})-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[oxidanyl(phosphonooxy)phosphoryl]phosphonamidic acid
A0I, [(2~{R},3~{S},4~{R},5~{R})-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-~{N}-[oxidanyl(phosphonooxy)phosphoryl]phosphonamidic acid (C9 H17 N4 O13 P3, 482.2 g/mol), in the MolNFT structures on…
- Component
- A0I
- Formula
- C9 H17 N4 O13 P3
- Class
- ligand
- Structures
- 2
- PDB entries
- 2
Binding sites
A0I in 2 structures; the first of them:
- 8PSX · Tilapia Lake Virus polymerase in vRNA elongation state (transcriptase conformation) · A0I B601 · binds ARG145, GLU148, LYS151, ARG155, ASP213, CYS214, THR215, LYS216 and 13 more
- 8PSZ · Tilapia Lake Virus polymerase in vRNA elongation state with additional mode B promoter… · A0I B601 · binds ARG145, GLU148, LYS151, ARG155, ASP213, CYS214, THR215, LYS216 and 14 more
Residues it binds most
LYS 2, ARG 2, ASN 2, ASP 2, GLU 2, MET 2, SER 2, A 2, CYS 2, G 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.